If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBLTG.L Regulatory News (BLTG)

  • There is currently no data for BLTG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Apex Fundrock Limited : Re Blancco Technology Group Plc

4 Oct 2023 13:40

Apex Fundrock Limited (MISL) Form 8.3 - Apex Fundrock Limited : Re Blancco Technology Group Plc 04-Oct-2023 / 13:39 GMT/BST


FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

 

1. KEY INFORMATION

 

(a) Full name of discloser:

MI Chelverton UK Equity Growth Fund

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

 The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

 Use a separate form for each offeror/offeree

Blancco Technology Group Plc

(ISIN: GB00B06GNN57)

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

 For an opening position disclosure, state the latest practicable date prior to the disclosure

3 October 2023

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

 If it is a cash offer or possible cash offer, state “N/A”

NO

If YES, specify which:

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

Ordinary 2p

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

3,750,000

 

4.95

N/A

 

(2) Cash-settled derivatives:

 

N/A

-

N/A

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

N/A

-

N/A

 

 

 TOTAL:

3,750,000

 

4.95

N/A

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors’ and other employee options)

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

Common 2p

 

SALE

 

 

307,923

 

2.2

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

N/A

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

N/A

 

 

 

 

 

 

 

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

N/A

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

N/A

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

4 October 2023

Contact name:

Apex Fund Administration Services (UK) Limited

Telephone number*:

01245 398950

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

 

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

 


Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.
Category Code:RET - Blancco Technology Group Plc
TIDM:MISL
LEI Code:549300P2JF82DYWEXW33
Sequence No.:275929
EQS News ID:1741457
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
9th Nov 20127:00 amRNSDirector/PDMR Shareholding
31st Oct 201212:06 pmRNSHolding(s) in Company
29th Oct 20127:00 amRNSRegenersis supports Samsung in new territory
12th Oct 20123:06 pmRNSHolding(s) in Company
12th Oct 201212:07 pmRNSHolding(s) in Company
11th Oct 20123:37 pmRNSHolding(s) in Company
11th Oct 201210:38 amRNSHolding(s) in Company
3rd Oct 20124:36 pmRNSHolding(s) in Company
3rd Oct 20122:20 pmRNSHolding(s) in Company
26th Sep 20129:43 amRNSDirector/PDMR Shareholding
25th Sep 20127:00 amRNSFinal Results
12th Sep 20127:00 amRNSNotice of Analyst Briefing - Change of Date
4th Sep 20127:00 amRNSNotice of Results
31st Aug 20122:48 pmRNSCompletion of Acquisition and Issue of Equity
26th Jul 20127:00 amRNSTrading Update and Acquisition
18th Jun 20129:34 amRNSChange of Registered Office
11th Jun 20128:32 amRNSDirector/PDMR Shareholding
1st Jun 20124:07 pmRNSHolding(s) in Company
30th May 201210:03 amRNSDirector/PDMR Shareholding
10th May 20128:39 amRNSDirector/PDMR Shareholding
9th May 20123:30 pmRNSHolding(s) in Company
2nd May 20122:57 pmRNSDirector/PDMR Shareholding
19th Apr 201211:07 amRNSDirector/PDMR Shareholding
4th Apr 20121:08 pmRNSHolding(s) in Company
28th Mar 20122:48 pmRNSHolding(s) in Company
13th Mar 20127:00 amRNSHalf Yearly Report
7th Mar 20123:11 pmRNSBoard Change
29th Feb 20129:00 amRNSNotice of Results
27th Feb 20124:22 pmRNSHolding(s) in Company
8th Feb 20129:53 amRNSHolding(s) in Company
12th Jan 20127:01 amRNSBoard Change
12th Jan 20127:00 amRNSTrading Update
3rd Jan 20129:11 amRNSHolding(s) in Company
22nd Dec 201110:49 amRNSDirector/PDMR Shareholding
29th Nov 201112:57 pmRNSResult of AGM
29th Nov 201111:55 amRNSAGM Trading Update
7th Oct 20115:17 pmRNSDirector/PDMR Shareholding
7th Oct 20119:00 amRNSHolding(s) in Company
29th Sep 20111:00 pmRNSDirector/PDMR Shareholding
28th Sep 20119:50 amRNSReport and Accounts Published
28th Sep 20117:00 amRNSPreliminary Results
22nd Jul 201110:24 amRNSDirector/PDMR Shareholding
4th Jul 201111:18 amRNSDirector/PDMR Shareholding
4th Jul 20117:00 amRNSAppointment of Joint Broker
29th Jun 201111:53 amRNSDirector/PDMR Shareholding
28th Jun 20117:00 amRNSTrading and Strategic Update
8th Jun 20119:03 amRNSDirector/PDMR Shareholding
31st May 20117:00 amRNSBusiness Update
23rd May 20114:19 pmRNSDirector/PDMR Shareholding
18th Mar 20117:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.